Sunniva Financial Statements From 2010 to 2024
Sunniva financial statements provide useful quarterly and yearly information to potential Sunniva investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Sunniva financial statements helps investors assess Sunniva's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Sunniva's valuation are summarized below:Sunniva does not presently have any fundamental trend indicators for analysis.
This module can also supplement various Sunniva Technical models . Check out the analysis of Sunniva Correlation against competitors.
Check Sunniva financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sunniva's main balance sheet or income statement drivers, such as , as well as many indicators such as . Sunniva financial statements analysis is a perfect complement when working with Sunniva Valuation or Volatility modules.
Sunniva |
Sunniva Company Return On Equity Analysis
Sunniva's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Sunniva Return On Equity | -0.64 |
Most of Sunniva's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sunniva is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Sunniva has a Return On Equity of -0.6406. This is 97.33% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is 106.65% higher than that of the company.
Sunniva Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sunniva's current stock value. Our valuation model uses many indicators to compare Sunniva value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sunniva competition to find correlations between indicators driving Sunniva's intrinsic value. More Info.Sunniva is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sunniva's earnings, one of the primary drivers of an investment's value.About Sunniva Financial Statements
Sunniva stakeholders use historical fundamental indicators, such as Sunniva's revenue or net income, to determine how well the company is positioned to perform in the future. Although Sunniva investors may analyze each financial statement separately, they are all interrelated. For example, changes in Sunniva's assets and liabilities are reflected in the revenues and expenses on Sunniva's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Sunniva. Please read more on our technical analysis and fundamental analysis pages.
Sunniva Inc., a vertically integrated cannabis company, focuses on the cultivation, production, and distribution of various therapeutic solutions in Canada and the United States. Sunniva Inc. was founded in 2014 and is headquartered in Vancouver, Canada. Sunniva operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in Sunniva Pink Sheet
Sunniva financial ratios help investors to determine whether Sunniva Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sunniva with respect to the benefits of owning Sunniva security.